1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by CNS Therapeutics Revenue
• 1.4 Market by Type
  • 1.4.1 Global CNS Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Neurodegenerative Diseases
  • 1.4.3 Mood Disorders
  • 1.4.4 Schizophrenia
  • 1.4.5 Autism
  • 1.4.6 Depression
• 1.5 Market by Application
  • 1.5.1 Global CNS Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital Use
  • 1.5.3 Clinic Use
  • 1.5.4 Household
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global CNS Therapeutics Market Perspective (2015-2026)
• 2.2 Global CNS Therapeutics Growth Trends by Regions
  • 2.2.1 CNS Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 CNS Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 CNS Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 CNS Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key CNS Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top CNS Therapeutics Players by Market Size
  • 3.1.1 Global Top CNS Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global CNS Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global CNS Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global CNS Therapeutics Market Concentration Ratio
  • 3.2.1 Global CNS Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by CNS Therapeutics Revenue in 2019
• 3.3 CNS Therapeutics Key Players Head office and Area Served
• 3.4 Key Players CNS Therapeutics Product Solution and Service
• 3.5 Date of Enter into CNS Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global CNS Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global CNS Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global CNS Therapeutics Market Size by Application (2015-2020)
• 5.2 Global CNS Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America CNS Therapeutics Market Size (2015-2020)
• 6.2 CNS Therapeutics Key Players in North America (2019-2020)
• 6.3 North America CNS Therapeutics Market Size by Type (2015-2020)
• 6.4 North America CNS Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe CNS Therapeutics Market Size (2015-2020)
• 7.2 CNS Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe CNS Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe CNS Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China CNS Therapeutics Market Size (2015-2020)
• 8.2 CNS Therapeutics Key Players in China (2019-2020)
• 8.3 China CNS Therapeutics Market Size by Type (2015-2020)
• 8.4 China CNS Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan CNS Therapeutics Market Size (2015-2020)
• 9.2 CNS Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan CNS Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan CNS Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia CNS Therapeutics Market Size (2015-2020)
• 10.2 CNS Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia CNS Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia CNS Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India CNS Therapeutics Market Size (2015-2020)
• 11.2 CNS Therapeutics Key Players in India (2019-2020)
• 11.3 India CNS Therapeutics Market Size by Type (2015-2020)
• 11.4 India CNS Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America CNS Therapeutics Market Size (2015-2020)
• 12.2 CNS Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America CNS Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America CNS Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Pfizer
  • 13.1.1 Pfizer Company Details
  • 13.1.2 Pfizer Business Overview
  • 13.1.3 Pfizer CNS Therapeutics Introduction
  • 13.1.4 Pfizer Revenue in CNS Therapeutics Business (2015-2020))
  • 13.1.5 Pfizer Recent Development
• 13.2 Janssen Pharmaceuticals
  • 13.2.1 Janssen Pharmaceuticals Company Details
  • 13.2.2 Janssen Pharmaceuticals Business Overview
  • 13.2.3 Janssen Pharmaceuticals CNS Therapeutics Introduction
  • 13.2.4 Janssen Pharmaceuticals Revenue in CNS Therapeutics Business (2015-2020)
  • 13.2.5 Janssen Pharmaceuticals Recent Development
• 13.3 Allergan
  • 13.3.1 Allergan Company Details
  • 13.3.2 Allergan Business Overview
  • 13.3.3 Allergan CNS Therapeutics Introduction
  • 13.3.4 Allergan Revenue in CNS Therapeutics Business (2015-2020)
  • 13.3.5 Allergan Recent Development
• 13.4 Lundbeck
  • 13.4.1 Lundbeck Company Details
  • 13.4.2 Lundbeck Business Overview
  • 13.4.3 Lundbeck CNS Therapeutics Introduction
  • 13.4.4 Lundbeck Revenue in CNS Therapeutics Business (2015-2020)
  • 13.4.5 Lundbeck Recent Development
• 13.5 Teva
  • 13.5.1 Teva Company Details
  • 13.5.2 Teva Business Overview
  • 13.5.3 Teva CNS Therapeutics Introduction
  • 13.5.4 Teva Revenue in CNS Therapeutics Business (2015-2020)
  • 13.5.5 Teva Recent Development
• 13.6 Camber Pharmaceuticals
  • 13.6.1 Camber Pharmaceuticals Company Details
  • 13.6.2 Camber Pharmaceuticals Business Overview
  • 13.6.3 Camber Pharmaceuticals CNS Therapeutics Introduction
  • 13.6.4 Camber Pharmaceuticals Revenue in CNS Therapeutics Business (2015-2020)
  • 13.6.5 Camber Pharmaceuticals Recent Development
• 13.7 Zhejiang Haisen Pharmaceutical
  • 13.7.1 Zhejiang Haisen Pharmaceutical Company Details
  • 13.7.2 Zhejiang Haisen Pharmaceutical Business Overview
  • 13.7.3 Zhejiang Haisen Pharmaceutical CNS Therapeutics Introduction
  • 13.7.4 Zhejiang Haisen Pharmaceutical Revenue in CNS Therapeutics Business (2015-2020)
  • 13.7.5 Zhejiang Haisen Pharmaceutical Recent Development
• 13.8 Jewim Pharmaceutical
  • 13.8.1 Jewim Pharmaceutical Company Details
  • 13.8.2 Jewim Pharmaceutical Business Overview
  • 13.8.3 Jewim Pharmaceutical CNS Therapeutics Introduction
  • 13.8.4 Jewim Pharmaceutical Revenue in CNS Therapeutics Business (2015-2020)
  • 13.8.5 Jewim Pharmaceutical Recent Development
• 13.9 Cipla
  • 13.9.1 Cipla Company Details
  • 13.9.2 Cipla Business Overview
  • 13.9.3 Cipla CNS Therapeutics Introduction
  • 13.9.4 Cipla Revenue in CNS Therapeutics Business (2015-2020)
  • 13.9.5 Cipla Recent Development
• 13.10 Merck Sharp & Dohme Corp.
  • 13.10.1 Merck Sharp & Dohme Corp. Company Details
  • 13.10.2 Merck Sharp & Dohme Corp. Business Overview
  • 13.10.3 Merck Sharp & Dohme Corp. CNS Therapeutics Introduction
  • 13.10.4 Merck Sharp & Dohme Corp. Revenue in CNS Therapeutics Business (2015-2020)
  • 13.10.5 Merck Sharp & Dohme Corp. Recent Development
• 13.11 Eli Lilly
  • 10.11.1 Eli Lilly Company Details
  • 10.11.2 Eli Lilly Business Overview
  • 10.11.3 Eli Lilly CNS Therapeutics Introduction
  • 10.11.4 Eli Lilly Revenue in CNS Therapeutics Business (2015-2020)
  • 10.11.5 Eli Lilly Recent Development
• 13.12 GlaxoSmithKline
  • 10.12.1 GlaxoSmithKline Company Details
  • 10.12.2 GlaxoSmithKline Business Overview
  • 10.12.3 GlaxoSmithKline CNS Therapeutics Introduction
  • 10.12.4 GlaxoSmithKline Revenue in CNS Therapeutics Business (2015-2020)
  • 10.12.5 GlaxoSmithKline Recent Development
• 13.13 Novartis
  • 10.13.1 Novartis Company Details
  • 10.13.2 Novartis Business Overview
  • 10.13.3 Novartis CNS Therapeutics Introduction
  • 10.13.4 Novartis Revenue in CNS Therapeutics Business (2015-2020)
  • 10.13.5 Novartis Recent Development
• 13.14 LUPIN
  • 10.14.1 LUPIN Company Details
  • 10.14.2 LUPIN Business Overview
  • 10.14.3 LUPIN CNS Therapeutics Introduction
  • 10.14.4 LUPIN Revenue in CNS Therapeutics Business (2015-2020)
  • 10.14.5 LUPIN Recent Development
• 13.15 ZYDUS PHARMS
  • 10.15.1 ZYDUS PHARMS Company Details
  • 10.15.2 ZYDUS PHARMS Business Overview
  • 10.15.3 ZYDUS PHARMS CNS Therapeutics Introduction
  • 10.15.4 ZYDUS PHARMS Revenue in CNS Therapeutics Business (2015-2020)
  • 10.15.5 ZYDUS PHARMS Recent Development
• 13.16 Biogen
  • 10.16.1 Biogen Company Details
  • 10.16.2 Biogen Business Overview
  • 10.16.3 Biogen CNS Therapeutics Introduction
  • 10.16.4 Biogen Revenue in CNS Therapeutics Business (2015-2020)
  • 10.16.5 Biogen Recent Development
• 13.17 Otsuka Pharmaceutical
  • 10.17.1 Otsuka Pharmaceutical Company Details
  • 10.17.2 Otsuka Pharmaceutical Business Overview
  • 10.17.3 Otsuka Pharmaceutical CNS Therapeutics Introduction
  • 10.17.4 Otsuka Pharmaceutical Revenue in CNS Therapeutics Business (2015-2020)
  • 10.17.5 Otsuka Pharmaceutical Recent Development
• 13.18 Astra Zeneca
  • 10.18.1 Astra Zeneca Company Details
  • 10.18.2 Astra Zeneca Business Overview
  • 10.18.3 Astra Zeneca CNS Therapeutics Introduction
  • 10.18.4 Astra Zeneca Revenue in CNS Therapeutics Business (2015-2020)
  • 10.18.5 Astra Zeneca Recent Development
• 13.19 Takeda
  • 10.19.1 Takeda Company Details
  • 10.19.2 Takeda Business Overview
  • 10.19.3 Takeda CNS Therapeutics Introduction
  • 10.19.4 Takeda Revenue in CNS Therapeutics Business (2015-2020)
  • 10.19.5 Takeda Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

CNS Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CNS Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Janssen Pharmaceuticals
Allergan
Lundbeck
Teva
Camber Pharmaceuticals
Zhejiang Haisen Pharmaceutical
Jewim Pharmaceutical
Cipla
Merck Sharp & Dohme Corp.
Eli Lilly
GlaxoSmithKline
Novartis
LUPIN
ZYDUS PHARMS
Biogen
Otsuka Pharmaceutical
Astra Zeneca
Takeda

Market segment by Type, the product can be split into
Neurodegenerative Diseases
Mood Disorders
Schizophrenia
Autism
Depression
Market segment by Application, split into
Hospital Use
Clinic Use
Household
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America